Rare Disease

Care4Rare is a nation-wide research program focusing on the improvement of both the diagnosis and treatment of rare diseases. Led out of the Children’s Hospital of Eastern Ontario (CHEO) Research Institute, CARE for RARE includes 21 academic sites across the country, and is recognized internationally as a pioneer in the field of genomics and personalized medicine.

Its team uses state of the art DNA sequencing technology to identify new rare disease genes for patients across Canada and around the world, and develops novel therapeutic approaches. Together, 80 physicians and 50 scientists work to advance rare disease research as part of the CARE for RARE program.

Currently, 25% rare disease patients wait 5-30 years for a diagnosis; 40% initially receive a misdiagnosis, and half will never receive a diagnosis. In contrast, the evidence-based approach being developed by CARE for RARE will result in an accurate rapid diagnosis for many affected by rare disease. Securing a clear diagnosis means that patients and families can make future projections about their healthcare, tap into best practice guidelines, seek reproductive counselling, and potentially start therapies.

In addition, only 5% of children with rare disease have access to an effective treatment. By investigating approved drugs for effectiveness in other diseases, CARE for RARE hopes to identify novel therapies for some of those currently without any treatment.

More information is also available at the Care4rare web page.

Related News

Research Projects

  1. Assessment of longitudinal bone growth in osteogenesis imperfecta using metacarpophalangeal pattern profiles

    27/07/2020

    COL1A1 and COL1A2 mutations affect bone growth not only by inducing fractures and bone deformities, but also through longitudinal growth deficits in bones that do not fracture or deform.

  2. Utility and practice of electrodiagnostic testing in the pediatric population: An AANEM consensus statement

    02/11/2019

    The panel found that electrodiagnostic studies continue to have high utility for the diagnosis of numerous childhood neuromuscular disorders, and that standardized approaches along with the use of high‐quality reference values are important to maximize the diagnostic yield of these tests in infants, children, and adolescents.

  3. ALU transposition induces familial hypertrophic cardiomyopathy

    01/09/2019

    Our results demonstrate that haploinsufficiency resulting from MYBPC3 complete deletion, potentially mediated by Alu recombination, is an important disease mechanism in cardiomyopathy and emphasizes the importance of copy number variation analysis in patients clinically suspected of HCM.

  4. Epilepsy genetics: Current knowledge, applications, and future directions

    01/07/2018

    Drug screening with in vitro and in vivo models of epilepsy can potentially facilitate new treatment strategies.

  5. Benefits of early referral to pediatric palliative care for a child with a rare disease

    01/06/2018

    This case is described to provide a voice for families who are caring for a child with an undiagnosed or life-limiting illness and especially for the families who won’t consider PPC either out of fear or not knowing it exists.

  6. Iron Overload In Transfusion-Dependent Survivors Of Hemoglobin Bart’s Hydrops Fetalis

    03/05/2018

    While homozygous α0-thalassemia is currently considered a rare disease, its prevalence is likely to rise given the high α0-thalassemia gene carrier rates in Southeast Asia coupled with recent advances in fetal medicine that is delivering improved access to intra-uterine transfusions.

  7. Addressing Challenges in the Diagnosis and Treatment of Rare Genetic Diseases

    01/03/2018

    Here, we discuss the increasing opportunity for diagnosis and therapy of rare diseases and how to tackle the associated challenges.

  8. International Cooperation to Enable the Diagnosis of All Rare Genetic Diseases

    05/05/2017

    Provision of a molecularly confirmed diagnosis in a timely manner for children and adults with rare genetic diseases shortens their "diagnostic odyssey," improves disease management, and fosters genetic counseling with respect to recurrence risks while assuring reproductive choices.

  9. Evidence for Clinical, Genetic and Biochemical Variability in Spinal Muscular Atrophy With Progressive Myoclonic Epilepsy

    01/12/2014

    The results of the WES and the functional studies prompted an electromyography (EMG) study that showed evidence of motor neuron disease despite only mild proximal muscle weakness.

  10. Mutations in PIK3R1 Cause SHORT Syndrome

    06/06/2013

    Our findings show that PIK3R1 mutations are the major cause of SHORT syndrome and suggest that the molecular mechanism of disease might involve downregulation of the PI3K-AKT-mTOR pathway.

  11. Targeted therapies for congenital myasthenic syndromes: systematic review and steps towards a treatabolome

    We assess the strength and quality of the evidence and create a dataset that provides the foundation for a computer-aided system to enable clinicians to gain easier access to information about treatable variants and the evidence they need to consider.

Researchers

  1. Ali Amid

    Investigator, CHEO Research Institute

    View Profile Email
  2. Kym M Boycott

    Senior Scientist, CHEO Research Institute

    View Profile Email
  3. David A. Dyment

    Investigator, CHEO Research Institute

    View Profile Email
  4. Olga Jarinova

    Investigator, CHEO Research Institute

    View Profile Email
  5. Hanns Lochmüller

    Senior Scientist, CHEO Research Institute

    View Profile Email
  6. Jean McGowan-Jordan

    Investigator, CHEO Research Institute

    View Profile Email
  7. Hugh McMillan

    Investigator, CHEO Research Institute

    View Profile Email
  8. Marie-Eve Robinson

    Investigator, CHEO Research Institute

    View Profile Email
  9. Christina Vadeboncoeur

    Investigator, CHEO Research Institute

    View Profile Email

Family Leaders

  1. Andy Statia

    View Profile
  2. Anne Maloney

    View Profile
  3. Barb Shantz

    View Profile
  4. Bina Sharma

    View Profile
  5. Bleadon Anderson

    View Profile
  6. Carolyn Stiff

    View Profile
  7. Christine Dalgleish

    View Profile
  8. Claire Dawe-McCord

    View Profile
  9. Ellen Song

    View Profile
  10. Erin Fobert

    View Profile
  11. Haishan Chen

    View Profile
  12. Jessica Hay

    View Profile
  13. Kate Stevens

    View Profile
  14. Keira Danson

    View Profile
  15. Kieran Peacock

    View Profile
  16. Laurie Woodward

    View Profile
  17. Leanne van der Zweep

    View Profile
  18. Linda Lefebvre

    View Profile
  19. Lisa Wadden

    View Profile
  20. Madleen Zapata-Martinez

    View Profile
  21. Mairead Green

    View Profile
  22. Mariann Michael

    View Profile
  23. Megan Gibbs

    View Profile
  24. Michel Laplante

    View Profile
  25. Natasha Baechler

    View Profile
  26. Samantha Bellefeuille

    View Profile
  27. Sheena Murphy

    View Profile
  28. Shelley Frappier

    View Profile
  29. Sophie Dagenais

    View Profile
  30. Tysen Lefebvre

    View Profile